We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

Back to rankings

72 hedge funds and large institutions have $345M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2013 Q2 according to their latest regulatory filings, with 72 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
+72
Holders Change %
–
% of All Funds
2.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
72
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$90M +$76.7M +4,289,073 New
DM
2
Deerfield Management
New York
$43.7M +$37.2M +2,082,167 New
CS
3
Credit Suisse
Switzerland
$42.2M +$36M +2,013,290 New
JP Morgan Chase
4
JP Morgan Chase
New York
$21.8M +$18.6M +1,038,653 New
Federated Hermes
5
Federated Hermes
Pennsylvania
$14.4M +$12.3M +687,100 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$14.3M +$12.2M +680,473 New
SAM
7
Sectoral Asset Management
Quebec, Canada
$12.8M +$10.9M +610,056 New
Jennison Associates
8
Jennison Associates
New York
$11.5M +$9.82M +549,657 New
VAM
9
Visium Asset Management
New York
$11.3M +$9.65M +540,000 New
Balyasny Asset Management
10
Balyasny Asset Management
Illinois
$9.47M +$8.07M +451,370 New
Goldman Sachs
11
Goldman Sachs
New York
$8.84M +$7.53M +421,280 New
BFA
12
BlackRock Fund Advisors
California
$7.93M +$6.75M +377,904 New
TCM
13
Tekla Capital Management
Massachusetts
$5.67M +$4.83M +270,031 New
BIT
14
BlackRock Institutional Trust
California
$4.6M +$3.92M +219,265 New
PCM
15
Penn Capital Management
Pennsylvania
$4.24M +$3.61M +202,031 New
Millennium Management
16
Millennium Management
New York
$3.65M +$3.11M +174,069 New
State Street
17
State Street
Massachusetts
$3.48M +$2.96M +165,890 New
Northern Trust
18
Northern Trust
Illinois
$3.47M +$2.96M +165,385 New
CII
19
CR Intrinsic Investors
Connecticut
$3.04M +$2.59M +145,150 New
HVC
20
Healthcare Value Capital
New Jersey
$2.16M +$1.84M +102,922 New
Bank of New York Mellon
21
Bank of New York Mellon
New York
$2.1M +$1.79M +100,205 New
BA
22
BlackRock Advisors
Delaware
$1.77M +$1.51M +84,348 New
Charles Schwab
23
Charles Schwab
California
$1.56M +$1.31M +73,032 New
TCIM
24
TIAA CREF Investment Management
New York
$1.4M +$1.19M +66,619 New
TC
25
TFS Capital
Pennsylvania
$1.31M +$1.11M +62,265 New
1
2 3

SGNT Hedge Fund Activity: Q2 2013 in Review

72 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q2 2013, worth a combined $345M.

Buyers outnumbered sellers: 72 funds opened new SGNT positions and 0 closed out — a net gain of 72 holders — while 0 added to existing stakes and 0 trimmed.

  • 72 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $345M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q2 2013.
  • 72 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q2 2013 and 0 closed out, a net change of +72 holders.

Based on aggregated 13F filings for Q2 2013.